XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.21.1

3. Intangible Assets, Goodwill and Other | 3 Months Ended
--- | ---
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets Disclosure | GOODWILL AND OTHER PURCHASED INTANGIBLE ASSETS Changes to goodwill by segment were as follows (in millions):
| Life Science |  | Clinical Diagnostics |  | Total
Balances as of March 31, 2021 and December 31, 2020: |  |  |  |  |
Goodwill | 277.9 |  |  | 349.2 |  |  | 627.1 |
Accumulated impairment losses | (41.8) |  |  | (293.4) |  |  | (335.2) |
Goodwill, net | $ | 236.1 |  |  | $ | 55.8 |  |  | $ | 291.9 |
Information regarding our identifiable purchased intangible assets with definite and indefinite lives is as follows (in millions):
| March 31, 2021
| Weighted-Average Remaining Amortization Period (years) |  | Purchase Price |  | Accumulated Amortization |  | Net Carrying Amount
Customer relationships/lists | 5.47 |  | $ | 112.4 |  |  | $ | (85.6) |  |  | $ | 26.8 |
Know how | 4.50 |  | 192.7 |  |  | (172.6) |  |  | 20.1 |
Developed product technology | 13.83 |  | 217.1 |  |  | (108.6) |  |  | 108.5 |
Licenses | 7.51 |  | 65.2 |  |  | (38.0) |  |  | 27.2 |
Tradenames | 7.71 |  | 6.4 |  |  | (4.2) |  |  | 2.2 |
Covenants not to compete | 3.66 |  | 4.6 |  |  | (2.2) |  |  | 2.4 |
Other | — |  | 0.1 |  |  | (0.1) |  |  | — |
Total definite-lived intangible assets |  |  | 598.5 |  |  | (411.3) |  |  | 187.2 |
In-process research and development |  |  | 4.6 |  |  | — |  |  | 4.6 |
Total purchased intangible assets |  |  | $ | 603.1 |  |  | $ | (411.3) |  |  | $ | 191.8 |
| December 31, 2020
| Weighted-Average Remaining Amortization Period (years) |  | Purchase Price |  | Accumulated Amortization |  | Net Carrying Amount
Customer relationships/lists | 5.51 |  | $ | 116.6 |  |  | $ | (87.2) |  |  | $ | 29.4 |
Know how | 4.75 |  | 196.6 |  |  | (175.4) |  |  | 21.2 |
Developed product technology | 14.00 |  | 218.1 |  |  | (107.1) |  |  | 111.0 |
Licenses | 7.73 |  | 65.6 |  |  | (37.4) |  |  | 28.2 |
Tradenames | 7.82 |  | 6.6 |  |  | (4.2) |  |  | 2.4 |
Covenants not to compete | 3.87 |  | 4.5 |  |  | (2.0) |  |  | 2.5 |
Other | — |  | 0.1 |  |  | (0.1) |  |  | — |
Total definite-lived intangible assets |  |  | 608.1 |  |  | (413.4) |  |  | 194.7 |
In-process research and development |  |  | 4.8 |  |  | — |  |  | 4.8 |
Total purchased intangible assets |  |  | $ | 612.9 |  |  | $ | (413.4) |  |  | $ | 199.5 |
Amortization expense related to purchased intangible assets is as follows (in millions):
| Three Months Ended |  |
| March 31, |  |
| 2021 |  | 2020 |  |  |  |
Amortization expense | $ | 7.2 |  |  | $ | 5.9 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration